腎生検の世界市場レポート 2025年

腎生検市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で28億米ドルに成長します。予測期間の成長は、腎臓疾患の有病率の増加、医療支出の増加、早期診断に対する意識の高まり、高齢者の拡大、低侵襲処置に対する需要の高まり、研究活動の活発化などに起因しています。予測期間における主要動向としては、生検技術の技術的進歩、低侵襲手技の採用、画像技術の進歩、精度向上のための人工知能の統合、生検装置の技術革新などが挙げられます。

腎がんの罹患率の増加は、腎生検市場の成長を促進する展望です。腎がんは、生活習慣の変化、環境毒素、高い発見率につながる診断方法の改善などの要因に影響され、異常な腎細胞の抑制されない増殖を伴います。腎生検は、がん細胞の存在を確認し、がんの病期を決定し、治療戦略を導き、治療反応をモニタリングし、予後に関する洞察を提供することにより、腎がんの診断と管理において重要な役割を果たしています。例えば、Cancer Research UKは、新たな腎臓がん症例が2023年の約16,300例から2025年には約21,900例に増加すると予測しており、腎生検サービスの需要が高まっていることを裏付けています。

腎生検市場の主要企業は、人工知能（AI）を統合して診断精度を高め、手順を合理化し、患者の転帰を最適化することで革新を進めています。AI技術は、画像解釈の強化、診断判断のサポート、治療計画の支援、予測分析の提供、腎臓病研究の推進などにより、腎生検分析を改善します。例えば、オランダのソフトウェア会社Aiosynは、2024年3月にNephroPathプラットフォームを発表しました。このプラットフォームは、腎生検の組織学的バイオマーカーを分析するための計算病理学的アルゴリズムを利用するもので、組織型の同定、間質性線維症の測定、糸球体の正確な定量化と評価などが含まれます。このようなAI主導の分析により、腎病理バイオマーカーの一貫性、詳細性、再現性のある評価が保証され、従来型スコアリング手法に伴う限界を克服し、観察者の主観性を軽減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の腎生検PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腎生検市場：成長率分析
• 世界の腎生検市場の実績：規模と成長、2019～2024年
• 世界の腎生検市場の予測：規模と成長、2024～2029年、2034年
• 世界の腎生検総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腎生検市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経皮生検
• 外科的生検
• 世界の腎生検市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 腎不全
• 腎臓移植
• 血尿
• タンパク尿
• 世界の腎生検市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• 泌尿器科センター
• 三次医療センター
• その他
• 世界の腎生検市場、経皮生検のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 超音波ガイド下生検
• CTガイド下生検
• MRI誘導生検
• 世界の腎生検市場、外科的生検のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 腎生検を開く
• 腹腔鏡手術腎生検

第7章 地域別・国別分析

• 世界の腎生検市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の腎生検市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腎生検市場：競合情勢
• 腎生検市場：企業プロファイル
  • Cardinal Health
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Thermo Fisher Scientific Inc.
  • AstraZeneca

第31章 その他の大手企業と革新的企業

• Medtronic
• Siemens Healthcare Private Limited
• Becton, Dickinson and Company
• Stryker Healthcare
• Baxter International Inc.
• Boston Scientific Corporation
• F. Hoffmann-La Roche Ltd.
• Zimmer Biomet
• Agilent Technologies Inc.
• Olympus Corporation
• Hitachi High-Tech Corporation
• Beckman Coulter Inc.
• B. Braun
• Sysmex Corporation
• Cook Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 腎生検市場、2029年：新たな機会を提供する国
• 腎生検市場、2029年：新たな機会を提供するセグメント
• 腎生検市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

A kidney biopsy, also referred to as a renal biopsy, is a medical procedure where a small sample of kidney tissue is extracted for microscopic analysis. This procedure is commonly conducted to diagnose kidney conditions, evaluate the severity of existing kidney diseases, or monitor treatment effectiveness. It plays a crucial role in identifying diverse kidney disorders such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, offering insights into the underlying causes of kidney dysfunction.

The primary types of kidney biopsy include percutaneous biopsy and surgical biopsy. Percutaneous biopsy involves inserting a needle through the skin to obtain tissue samples from the kidney for examination. This method is utilized in various clinical settings including cases of kidney failure, kidney transplantation, hematuria, and proteinuria. It is employed by hospitals, clinics, urology centers, tertiary care centers, and other healthcare facilities.

The kidney biopsy market research report is one of a series of new reports from The Business Research Company that provides kidney biopsy market statistics, including the kidney biopsy industry global market size, regional shares, competitors with kidney biopsy market share, detailed kidney biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney biopsy industry. These kidney biopsy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney biopsy market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.

The increasing incidence of renal cancer is poised to drive growth in the kidney biopsy market. Renal cancer involves the unchecked proliferation of abnormal kidney cells, influenced by factors such as lifestyle changes, environmental toxins, and improved diagnostic methods leading to higher detection rates. Kidney biopsies play a crucial role in diagnosing and managing renal cancer by confirming the presence of cancerous cells, determining cancer stage, guiding treatment strategies, monitoring treatment response, and providing prognostic insights. For example, Cancer Research UK projects an anticipated rise in new kidney cancer cases from approximately 16,300 in 2023 to about 21,900 by 2025, underscoring the escalating demand for kidney biopsy services.

Leading companies in the kidney biopsy market are innovating by integrating artificial intelligence (AI) to enhance diagnostic precision, streamline procedures, and optimize patient outcomes. AI technology improves kidney biopsy analysis by enhancing image interpretation, supporting diagnostic decisions, assisting in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, Aiosyn, a Netherlands-based software firm, introduced the NephroPath platform in March 2024. This platform utilizes computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including tissue type identification, measurement of interstitial fibrosis, and precise quantification and evaluation of glomeruli. Such AI-driven analysis ensures consistent, detailed, and reproducible assessment of renal pathology biomarkers, overcoming limitations associated with traditional scoring methods and reducing observer subjectivity.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products for $176 million. This strategic acquisition enhances Halma plc's footprint in the kidney biopsy sector by integrating IZI Medical's advanced core biopsy devices. These devices are utilized across various anatomical sites, including kidneys, thyroid, intra-abdominal areas, and liver, aimed at improving the safety, accuracy, and efficacy of biopsy procedures. This acquisition underscores Halma plc's commitment to advancing biopsy technologies to benefit both patients and healthcare providers.

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

North America was the largest region in the kidney biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kidney biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kidney biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Percutaneous Biopsy; Surgical Biopsy
• 2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria
• 3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users
• Subsegments:
• 1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy; CT-Guided Biopsy; MRI-Guided Biopsy
• 2) By Surgical Biopsy: Open Kidney Biopsy; Laparoscopic Kidney Biopsy
• Companies Mentioned: Cardinal Health; Pfizer Inc.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; AstraZeneca
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kidney Biopsy Market Characteristics

3. Kidney Biopsy Market Trends And Strategies

4. Kidney Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Kidney Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Kidney Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Kidney Biopsy Market Growth Rate Analysis
• 5.4. Global Kidney Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Kidney Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Kidney Biopsy Total Addressable Market (TAM)

6. Kidney Biopsy Market Segmentation

• 6.1. Global Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Percutaneous Biopsy
• Surgical Biopsy
• 6.2. Global Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kidney Failure
• Kidney Transplant
• Hematuria
• Proteinuria
• 6.3. Global Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Urology Centers
• Tertiary Care Centers
• Other End-Users
• 6.4. Global Kidney Biopsy Market, Sub-Segmentation Of Percutaneous Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound-Guided Biopsy
• CT-Guided Biopsy
• MRI-Guided Biopsy
• 6.5. Global Kidney Biopsy Market, Sub-Segmentation Of Surgical Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Kidney Biopsy
• Laparoscopic Kidney Biopsy

7. Kidney Biopsy Market Regional And Country Analysis

• 7.1. Global Kidney Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Kidney Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Kidney Biopsy Market

• 8.1. Asia-Pacific Kidney Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Kidney Biopsy Market

• 9.1. China Kidney Biopsy Market Overview
• 9.2. China Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Kidney Biopsy Market

• 10.1. India Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Kidney Biopsy Market

• 11.1. Japan Kidney Biopsy Market Overview
• 11.2. Japan Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Kidney Biopsy Market

• 12.1. Australia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Kidney Biopsy Market

• 13.1. Indonesia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Kidney Biopsy Market

• 14.1. South Korea Kidney Biopsy Market Overview
• 14.2. South Korea Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Kidney Biopsy Market

• 15.1. Western Europe Kidney Biopsy Market Overview
• 15.2. Western Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Kidney Biopsy Market

• 16.1. UK Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Kidney Biopsy Market

• 17.1. Germany Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Kidney Biopsy Market

• 18.1. France Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Kidney Biopsy Market

• 19.1. Italy Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Kidney Biopsy Market

• 20.1. Spain Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Kidney Biopsy Market

• 21.1. Eastern Europe Kidney Biopsy Market Overview
• 21.2. Eastern Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Kidney Biopsy Market

• 22.1. Russia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Kidney Biopsy Market

• 23.1. North America Kidney Biopsy Market Overview
• 23.2. North America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Kidney Biopsy Market

• 24.1. USA Kidney Biopsy Market Overview
• 24.2. USA Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Kidney Biopsy Market

• 25.1. Canada Kidney Biopsy Market Overview
• 25.2. Canada Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Kidney Biopsy Market

• 26.1. South America Kidney Biopsy Market Overview
• 26.2. South America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Kidney Biopsy Market

• 27.1. Brazil Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Kidney Biopsy Market

• 28.1. Middle East Kidney Biopsy Market Overview
• 28.2. Middle East Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Kidney Biopsy Market

• 29.1. Africa Kidney Biopsy Market Overview
• 29.2. Africa Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Kidney Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Kidney Biopsy Market Competitive Landscape
• 30.2. Kidney Biopsy Market Company Profiles
  • 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

31. Kidney Biopsy Market Other Major And Innovative Companies

• 31.1. Medtronic
• 31.2. Siemens Healthcare Private Limited
• 31.3. Becton, Dickinson and Company
• 31.4. Stryker Healthcare
• 31.5. Baxter International Inc.
• 31.6. Boston Scientific Corporation
• 31.7. F. Hoffmann-La Roche Ltd.
• 31.8. Zimmer Biomet
• 31.9. Agilent Technologies Inc.
• 31.10. Olympus Corporation
• 31.11. Hitachi High-Tech Corporation
• 31.12. Beckman Coulter Inc.
• 31.13. B. Braun
• 31.14. Sysmex Corporation
• 31.15. Cook Medical

32. Global Kidney Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kidney Biopsy Market

34. Recent Developments In The Kidney Biopsy Market

35. Kidney Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Kidney Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Kidney Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Kidney Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer